Literature DB >> 18404727

Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy.

Young-Hoon Jeong1, Kee-Joon Choi, Jong-Min Song, Eui-Seock Hwang, Kyoung-Min Park, Gi-Byoung Nam, Jae-Joong Kim, You-Ho Kim.   

Abstract

BACKGROUND: Due to the absence of differential guidelines for heart failure with tachyarrhythmia, it is difficult to diagnose tachycardia-induced cardiomyopathy (TIC) at the initial visit. Furthermore, clinical outcomes of rate versus rhythm control in TIC are unclear. HYPOTHESIS: Because the etiology of TIC is different from dynamic cardiomyoplasty (DCMP), differential parameters may be present.
METHODS: We assessed 21 patients with TIC (15 men; mean age, 50+/-14 years) and 21 control patients with idiopathic DCMP. We assessed clinical courses, echocardiographic parameters, as well as outcomes by treatment.
RESULTS: In the TIC group, the related tachyarrhythmias were atrial fibrillation (n=12), atrial flutter (n=5), atrial tachycardia (n=3) and paroxysmal supraventricular tachycardia (n=1). After treatment, all patients became asymptomatic and the ejection fraction (EF) improvement (DeltaEF>or=15%) was observed in all patients (left ventricular ejection fraction [LVEF], 30+/-11%initial versus 58+/-6%last). In the idiopathic DCMP group, no patient showed EF improvement (EF increase<or=5%), and 4 patients (19%) underwent heart transplantation. Left ventricle (LV) mass indices, volumes adjusted by BSA, and dimensions were smaller in the TIC group than in the idiopathic DCMP group. Of those, LV end-diastolic dimension was the only independent predictor of TIC in multiple regression analysis (odds ratio [OR] 0.742 per 1 mm, 95% confidence ratio [CI] 0.618 to 0.891, p=0.001). The Association of University Cardiologists (AUC) was 0.908 on receiver-operating characteristic (ROC) curve analysis and LV end-diastolic dimension<or=61% mm could predict TIC with a sensitivity of 100% and a specificity of 71.4%. After restoration of sinus rhythm (n=8), one experienced recurrent TIC after discontinuation of amiodarone. After control of heart rate (n=13), one experienced recurrent TIC due to poor control of heart rate (log-rank test, p=0.808). There were no differences in the echocardiographic parameters between the 2 groups before and after treatment except for the larger initial LV volumes in the rhythm control.
CONCLUSIONS: In patients presented as heart failure with tachyarrhythmia, initial echocardiographic parameters, especially LV end-diastolic dimension, help to differentiate TIC from idiopathic DCMP. Rate control was as effective as rhythm control for EF improvement and prognosis. Copyright (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18404727      PMCID: PMC6653168          DOI: 10.1002/clc.20161

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  25 in total

1.  Stress-related cardiomyopathies.

Authors:  Christian Richard
Journal:  Ann Intensive Care       Date:  2011-09-20       Impact factor: 6.925

2.  Reversible cardiomyopathy after radiofrequency ablation of 30-year persistent atrial tachycardia.

Authors:  Atsushi Suzuki; Tsuyoshi Shiga; Kotaro Arai; Morio Shoda
Journal:  BMJ Case Rep       Date:  2013-12-10

3.  Impact of radiofrequency catheter ablation on echocardiographic and cardiopulmonary performance in patients with ventricular extrasystolic beats and suspected arrhythmia-induced cardiomyopathy.

Authors:  Tomasz Krynski; Sebastian Stec; Sebastian Szmit; Beata Zaborska; Paweł Balsam; Piotr Kulakowski; Grzegorz Opolski
Journal:  Heart Vessels       Date:  2014-11       Impact factor: 2.037

Review 4.  Arrhythmia-Induced Cardiomyopathy.

Authors:  Samuel Sossalla; Dirk Vollmann
Journal:  Dtsch Arztebl Int       Date:  2018-05-11       Impact factor: 5.594

Review 5.  Tachycardia-mediated cardiomyopathy: recognition and management.

Authors:  Rakesh Gopinathannair; Renee Sullivan; Brian Olshansky
Journal:  Curr Heart Fail Rep       Date:  2009-12

6.  Tachycardia-induced cardiomyopathy.

Authors:  Bruno Tsutomu Nakatani; Marcos Ferreira Minicucci; Katashi Okoshi; Marina Politi Okoshi
Journal:  BMJ Case Rep       Date:  2012-09-21

Review 7.  Heart failure and tachycardia-induced cardiomyopathy.

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 8.  Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.

Authors:  Rakesh Gopinathannair; Susan P Etheridge; Francis E Marchlinski; Francis G Spinale; Dhanunjaya Lakkireddy; Brian Olshansky
Journal:  J Am Coll Cardiol       Date:  2015-10-13       Impact factor: 24.094

Review 9.  Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases.

Authors:  Adam Mohmand-Borkowski; W H Wilson Tang
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

10.  What About Tachycardia-induced Cardiomyopathy?

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.